Von Graevenitz et al., 1971 - Google Patents
Pathogenic significance of Pseudomonas fluorescens and Pseudomonas putida.Von Graevenitz et al., 1971
View PDF- Document ID
- 7239301368571561884
- Author
- Von Graevenitz A
- Weinstein J
- Publication year
- Publication venue
- The Yale journal of biology and medicine
External Links
Snippet
ISOLATION AND IDENTIFICATION Urines, sputa, and throat swabs were inoculated on aerobic blood agar* and Desoxycholate Agar** plates; pleural fluid, wound, and pus specimens also on anaerobic kanamycin-blood agar plates and into Fluid Thioglycollate …
- 241000589540 Pseudomonas fluorescens 0 title abstract description 24
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/04—Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Micro-organisms
- Y10S435/822—Micro-organisms using bacteria or actinomycetales
- Y10S435/874—Pseudomonas
- Y10S435/875—Pseudomonas aeruginosa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—PROCESSES USING MICRO-ORGANISMS
- C12R1/00—Processes using micro-organisms
- C12R1/01—Processes using micro-organisms using bacteria or actinomycetales
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Micro-organisms
- Y10S435/822—Micro-organisms using bacteria or actinomycetales
- Y10S435/873—Proteus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Bacteriophages
- C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Von Graevenitz et al. | Pathogenic significance of Pseudomonas fluorescens and Pseudomonas putida. | |
Gregg et al. | Effects of sphincteroplasty and endoscopic sphincterotomy on the bacteriologic characteristics of the common bile duct | |
ROSENTHAL et al. | Prevalence of gram-negative rods in the normal pharyngeal flora | |
Yabuuchi et al. | Achromobacter xylosoxidans n. sp. from human ear discharge | |
Hammond et al. | Antimicrobial susceptibility of Haemophilus ducreyi | |
Freter et al. | Function of various intestinal bacteria in converting germfree mice to the normal state | |
Holmes et al. | Flavobacterium odoratum: a species resistant to a wide range of antimicrobial agents. | |
Savage | Associations of indigenous microorganisms with gastrointestinal mucosal epithelia | |
Andrews et al. | Bacteriology of normal and diseased gallbladders | |
Møller et al. | Changing patterns of plasmid-mediated drug resistance during tetracycline therapy | |
Hollis et al. | Tatumella ptyseos gen. nov., sp. nov., a member of the family Enterobacteriaceae found in clinical specimens | |
Boniece et al. | In vitro and in vivo laboratory evaluation of cephalothin, a new broad spectrum antibiotic | |
Barker et al. | Characteristics of some co-trimoxazole-resistant Enterobacteriaceae from infected patients | |
MEYERS et al. | Infections caused by microorganisms of the genus Erwinia | |
D'Herelle | Studies upon Asiatic cholera | |
Schoen et al. | Infection with CDC group DF-2 gram-negative rod: report of two cases | |
Mindolli | Dentification and Speciation of Acinetobacter and their Antimicrobial Susceptibility Testing | |
Dan et al. | Peritonitis caused by Pseudomonas putrefaciens in patients undergoing continuous ambulatory peritoneal dialysis | |
Matsen et al. | Characterization of indole-positive Proteus mirabilis | |
Chang | Studies on Entamoeba Histolytica: V. On the Decrease in Infectivity and Pathogenicity for Kittens of E. Histolytica During Prolonged in Vitro Cultivation and Restoration of These Characters Following Encystment and Direct Animal Passage | |
Chatterjee et al. | Vibrio parahaemolyticus and diarrhoea associated with non-cholera vibrios. | |
Fujita et al. | Pseudomonas pickettii bacteremia | |
King et al. | Infection caused by thymidine-requiring, trimethoprim-resistant bacteria | |
Altmann et al. | Citrobacter diversus isolated from clinical material | |
Hofstad et al. | Subacute bacterial endocarditis due to Actinobacillus actinomycetemcomitans |